Pharmafile Logo
Pharmafocus logo
Advanced Search
Shire UK

Shire makes $750m regenerative medicines acquisition

May 18, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine

Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …

News

Mark Dean-Netscher joins Penn Pharma

May 18, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …

Appointment

Prime Minister stands by radical NHS shake up

May 17, 2011
Health and Social Care Bill, NHS reforms

Prime Minister David Cameron is standing firm on the government’s planned restructuring of the NHS despite mounting opposition. Cameron was …

News
Eli Lilly and Company

Lilly accused of anti-competitive practices

May 17, 2011
Amylin, Boehringer, diabetes, exenatide, lilly, linagliptin

Amylin Pharmaceuticals is suing Eli Lilly and Company for alleged anticompetitive activity around Lilly’s January agreement with Boehringer Ingelheim to …

News

Teva plans Japan expansion with Taiyo buy

May 17, 2011
Sales and Marketing Taiyo, Teva, generics

Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …

News
Lonza Visp Switzerland

Lonza invests again in Visp high-potency capacity

May 17, 2011
Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production

Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …

News

HIV drug Prezista recalled on TBA contamination

May 17, 2011
Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls

Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …

News

Pharma manufacturing news in brief

May 17, 2011
Manufacturing and Production manufacturing and production

There are new facilities for Alexion, Biovest and Pharmascience, a production contract for Dalton Pharma Services and progress in Codexis’ …

News

Dr Thomas Bieringer to head up Bayer technology centre

May 17, 2011
Manufacturing and Production appointment, manufacturing and production

Bayer has appointed Dr Thomas Bieringer as managing director of INVITE GmbH, a joint research venture with the Technical University …

Appointment

Sanofi strikes Crohn’s deal with Glenmark

May 16, 2011
Research and Development Crohn’s disease, Glenmark, Sanofi

Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …

News

Shield Therapeutics appoints finance chief

May 16, 2011
Sales and Marketing appointment, sales and marketing

Swiss specialty pharma company Shield Therapeutics has appointed Richard Jones to the newly-created role of chief financial officer. He has …

Appointment
Merck & Co's Victrelis (boceprevir)

Merck’s hepatitis drug Victrelis approved by FDA

May 16, 2011
Sales and Marketing Merck & Co, Victrelis, boceprevir, hepatitis C

The FDA has approved Merck’s hepatitis C drug Victrelis, the first oral treatment for the disease. Victrelis (boceprevir) has been …

News
ABPI's London offices

ABPI and BIA move in together

May 16, 2011
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …

News

It’s time we redesigned the clinical trial

May 16, 2011
Research and Development clinical trials, randomised controlled trials

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …

Feature

Price concession helps change NICE’s mind on Simponi

May 13, 2011
Sales and Marketing NICE, Simponi, TNF, merck sharp and dohme

NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …

News

Takeda denies $12bn Nycomed takeover reports

May 13, 2011
Research and Development, Sales and Marketing Nycomed, Takeda

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …

News
European Parliament

EMA under fire from European Parliament

May 13, 2011
Medical Communications, Research and Development, Sales and Marketing EMA, European Parliament, MEPs

The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …

News

Publicis acquires Beijing-based healthcare agency

May 13, 2011
Medical Communications Publicis Life Brands Dreams, Publicis Life Brands Watermelon, medical communications agency, publicis

Publicis has acquired Dreams Communication, a Chinese agency specialising in healthcare communications. Dreams will become part of Publicis Healthcare Communications …

News

NHS Alliance defends GP commissioning

May 13, 2011
GP commissioning, NHS Alliance, NHS reforms

The NHS Alliance has issued a staunch defence of the principle of GP commissioning – but warned the government to …

News
GlaxoSmithKline

GSK and AZ collaborate on translational research centre

May 12, 2011
Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026